ENRIGHT PATRICK G — SEC insider filings

SEC reporting owner CIK 1253886. 52 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers the 50 most recent of 52 filings on record, filed 2020-09-23 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Veradermics, Inc (MANE)Director22 legs · 1,075,000 sh · $18,275,0002 legs · 500,000 sh · $75,190,0007
Vera Therapeutics, Inc. (VERA)Director118 legs · 3,212,590 sh · $32,527,276—8
Zenas BioPharma, Inc. (ZBIO)Director43 legs · 557,255 sh · $9,730,026—9
BioAge Labs, Inc. (BIOA)Director31 leg · 400,000 sh · $7,200,000—5
Lexeo Therapeutics, Inc. (LXEO)10% owner11 leg · 454,545 sh · $4,999,995—4
Inozyme Pharma, Inc. (INZY)10% owner11 leg · 1,355,000 sh · $4,999,950——
Sierra Oncology, Inc. (SRRA)10% owner31 leg · 175,000 sh · $4,725,000—10
Eargo, Inc. (EAR)10% owner21 leg · 233,333 sh · $4,199,994—4
Talaris Therapeutics, Inc. (TALS)10% owner11 leg · 235,000 sh · $3,995,000—4
RAPID MICRO BIOSYSTEMS, INC. (RPID)10% owner31 leg · 150,000 sh · $3,000,0005 legs · 157,739 sh · $663,94911

+4 more issuers among the filings shown — every filing appears in the table below.

Insider filings — ENRIGHT PATRICK G

FiledFormIssuerReported transactionsSource
2026-11-134Veradermics, Inc (MANE)Sale (S): 250,000 @ $150.38 · Sale (S): 250,000 @ $150.38EDGAR
2026-09-024Jazz Pharmaceuticals plc (JAZZ)Tax withholding (F): 14 @ $244.64 · Tax withholding (F): 1,692 @ $241.39EDGAR
2026-08-074Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 1,605 @ $0EDGAR
2026-06-174Zenas BioPharma, Inc. (ZBIO)Grant/award (A): 18,500 (derivative) @ $0EDGAR
2026-06-124BioAge Labs, Inc. (BIOA)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2026-05-264Vera Therapeutics, Inc. (VERA)Grant/award (A): 17,084 (derivative) @ $0EDGAR
2026-02-064RAPID MICRO BIOSYSTEMS, INC. (RPID)
jointly with Longitude Capital Partners II, LLC, Longitude Venture Partners II, L.P., Longitude Prime Partners, LLC, Longitude Prime Fund, L.P., Tammenoms Bakker Juliet
Sale (S): 49,000 @ $3.88EDGAR
2026-02-054Veradermics, Inc (MANE)Conversion (C): 1,236,631 · Conversion (C): 1,171,121 · Conversion (C): 1,171,121 · Purchase (P): 192,647 @ $17 · Purchase (P): 882,353 @ $17 · Conversion (C): 1,236,631 (derivative) · +3 moreEDGAR
2026-02-034RAPID MICRO BIOSYSTEMS, INC. (RPID)
jointly with Longitude Capital Partners II, LLC, Longitude Venture Partners II, L.P., Longitude Prime Partners, LLC, Tammenoms Bakker Juliet
Option exercise/expiry (X): 629,032 @ $0.05 · Sale (S): 7,739 @ $4.06 · Sale (S): 46,000 @ $4.54 · Sale (S): 27,500 @ $4.25 · Sale (S): 27,500 @ $4.24 · Option exercise/expiry (X): 500,000 (derivative) @ $0 · +1 moreEDGAR
2026-01-084Jazz Pharmaceuticals plc (JAZZ)Other (J): 5,000 @ $0EDGAR
2025-12-154Vera Therapeutics, Inc. (VERA)Purchase (P): 5,882 @ $42.50EDGAR
2025-10-144Zenas BioPharma, Inc. (ZBIO)Purchase (P): 105,265 @ $19 · Purchase (P): 11,990 @ $20.85EDGAR
2025-08-114Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 3,507 @ $0 · Tax withholding (F): 1,805 @ $111.25EDGAR
2025-06-254Vera Therapeutics, Inc. (VERA)Purchase (P): 69,798 @ $20.87 · Purchase (P): 139,595 @ $20.87 · Purchase (P): 13,536 @ $22.35 · Purchase (P): 27,071 @ $22.35EDGAR
2025-06-124Zenas BioPharma, Inc. (ZBIO)Grant/award (A): 18,500 (derivative) @ $0EDGAR
2025-06-094BioAge Labs, Inc. (BIOA)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2025-05-164Vera Therapeutics, Inc. (VERA)Grant/award (A): 14,000 (derivative) @ $0EDGAR
2024-09-274BioAge Labs, Inc. (BIOA)Conversion (C): 1,310,589 · Purchase (P): 400,000 @ $18 · Grant/award (A): 15,000 (derivative) @ $0 · Conversion (C): 5,848,637 (derivative)EDGAR
2024-09-164Zenas BioPharma, Inc. (ZBIO)Conversion (C): 723,812 · Conversion (C): 1,003,592 · Conversion (C): 334,530 · Purchase (P): 440,000 @ $17 · Conversion (C): 6,284,933 (derivative) · Conversion (C): 8,714,293 (derivative) · +2 moreEDGAR
2024-08-064Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 3,731 @ $0EDGAR
2024-05-174Vera Therapeutics, Inc. (VERA)Grant/award (A): 14,000 (derivative) @ $0EDGAR
2023-11-094Lexeo Therapeutics, Inc. (LXEO)
jointly with Longitude Capital Partners IV, LLC, Longitude Venture Partners IV, L.P., Tammenoms Bakker Juliet
Conversion (C): 1,793,429 · Conversion (C): 319,126 · Purchase (P): 454,545 @ $11 · Conversion (C): 18,999,999 (derivative) · Conversion (C): 2,906,148 (derivative)EDGAR
2023-08-154Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 3,075 @ $0 · Sale (S): 1,241 @ $138.16EDGAR
2023-05-124Vera Therapeutics, Inc. (VERA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-02-084Vera Therapeutics, Inc. (VERA)Purchase (P): 1,714,285 @ $7EDGAR
2022-11-254Jazz Pharmaceuticals plc (JAZZ)Sale (S): 2,905 @ $149.18 · Sale (S): 2,069 @ $149.90 · Sale (S): 2,000 @ $152.88EDGAR
2022-08-094Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 2,561 @ $0 · Sale (S): 1,089 @ $152.33EDGAR
2022-05-314Aptinyx Inc. (APTX)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2022-05-264Vera Therapeutics, Inc. (VERA)Grant/award (A): 9,925 (derivative) @ $0EDGAR
2022-04-294Sierra Oncology, Inc. (SRRA)
jointly with Longitude Capital Partners III, LLC, Longitude Venture Partners III, L.P., Tammenoms Bakker Juliet, Longitude Prime Partners, LLC, Longitude Prime Fund, L.P.
Other (J): 175,000 @ $0 · Other (J): 1,964,771 @ $0 · Other (J): 5,023 @ $0 · Other (J): 2,152 @ $0 · Other (J): 7,175 @ $0 · Other (J): 588 @ $0 · +2 moreEDGAR
2022-04-214Inozyme Pharma, Inc. (INZY)
jointly with Longitude Capital Partners III, LLC, Longitude Venture Partners III, L.P., Tammenoms Bakker Juliet
Purchase (P): 1,355,000 @ $3.69EDGAR
2022-04-054Vera Therapeutics, Inc. (VERA)Purchase (P): 333,333 @ $15EDGAR
2022-02-024Sierra Oncology, Inc. (SRRA)
jointly with Longitude Capital Partners III, LLC, Longitude Venture Partners III, L.P., Tammenoms Bakker Juliet, Longitude Prime Partners, LLC, Longitude Prime Fund, L.P.
Purchase (P): 175,000 @ $27EDGAR
2022-01-274Sierra Oncology, Inc. (SRRA)
jointly with Longitude Capital Partners III, LLC, Longitude Venture Partners III, L.P., Tammenoms Bakker Juliet
Option exercise/expiry (X): 487,451 @ $13.20 · Option exercise/expiry (X): 1,477,125 (derivative) @ $13.20EDGAR
2021-08-204Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 2,000 @ $137.75EDGAR
2021-08-024Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 2,246 @ $0EDGAR
2021-07-204RAPID MICRO BIOSYSTEMS, INC. (RPID)
jointly with Longitude Capital Partners II, LLC, Longitude Venture Partners II, L.P., Longitude Prime Partners, LLC, Longitude Prime Fund, L.P., Tammenoms Bakker Juliet
Conversion (C): 3,344,038 @ $0 · Purchase (P): 150,000 @ $20 · Conversion (C): 8,774,007 (derivative) @ $0 · Conversion (C): 5,654,529 (derivative) @ $0 · Conversion (C): 2,291,665 (derivative) @ $0 · Conversion (C): 2,500,000 (derivative) @ $0 · +3 moreEDGAR
2021-06-014Aptinyx Inc. (APTX)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2021-05-184Vera Therapeutics, Inc. (VERA)Conversion (C): 2,187,504 · Purchase (P): 909,090 @ $11 · Conversion (C): 2,187,504 (derivative) @ $0EDGAR
2021-05-174Vera Therapeutics, Inc. (VERA)Grant/award (A): 9,925 (derivative) @ $0EDGAR
2021-05-114Talaris Therapeutics, Inc. (TALS)
jointly with Longitude Capital Partners III, LLC, Longitude Venture Partners III, L.P., Tammenoms Bakker Juliet
Conversion (C): 2,985,775 · Purchase (P): 235,000 @ $17 · Conversion (C): 1,308,410 (derivative) @ $0 · Conversion (C): 1,271,027 (derivative) @ $0 · Conversion (C): 406,338 (derivative) @ $0EDGAR
2021-04-154Eargo, Inc. (EAR)
jointly with Longitude Venture Partners IV, L.P., Longitude Capital Partners IV, LLC
Other (J): 1,000,000 @ $0 · Other (J): 5,012 @ $0EDGAR
2021-01-054Aptinyx Inc. (APTX)Grant/award (A): 8,149 (derivative) @ $2.22EDGAR
2020-11-18489bio, Inc. (ETNB)
jointly with Longitude Capital Partners III, LLC, Longitude Venture Partners III, L.P., Tammenoms Bakker Juliet
Other (J): 850,000 @ $0 · Other (J): 2,973 @ $0 · Other (J): 2,080 @ $0 · Other (J): 891 @ $0EDGAR
2020-11-134Jazz Pharmaceuticals plc (JAZZ)Sale (S): 3,223 @ $145.81 · Sale (S): 5,083 @ $147.00 · Sale (S): 1,623 @ $147.61EDGAR
2020-11-044Jazz Pharmaceuticals plc (JAZZ)Option exercise (M): 9,929 · Option exercise (M): 9,929 (derivative)EDGAR
2020-10-224Eargo, Inc. (EAR)
jointly with Longitude Venture Partners IV, L.P., Longitude Capital Partners IV, LLC
Conversion (C): 3,685,358 · Purchase (P): 233,333 @ $18 · Conversion (C): 3,685,358 (derivative) @ $0EDGAR
2020-10-144Aimmune Therapeutics, Inc. (AIMT)Code (U): 70,561 @ $34.50 · Code (U): 91,697 @ $34.50 · Disposition to issuer (D): 7,840 @ $34.50 · Disposition to issuer (D): 65,849 (derivative) @ $34.36 · Disposition to issuer (D): 52,421 (derivative) @ $28.21 · Disposition to issuer (D): 19,755 (derivative) @ $19.10 · +4 moreEDGAR
2020-10-024Aptinyx Inc. (APTX)Grant/award (A): 8,379 (derivative) @ $2.16EDGAR
2020-09-234Aimmune Therapeutics, Inc. (AIMT)Other (J): 6,113,134 @ $0 · Other (J): 91,697 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1253886 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs